https://www.selleckchem.com/products/MK-1775.html
SSc hallmark antibodies may predict increased risk of SSc-GI disease, in particular ACA and ARA, whilst PM-Scl may be protective. There is a significant burden of SSc-GI disease in patients with SSc; reflux and bloating symptoms are most prominent. SSc hallmark antibodies may predict increased risk of SSc-GI disease, in particular ACA and ARA, whilst PM-Scl may be protective.The receptor-like kinases (RLKs) CLAVATA1 (CLV1) and BARELY ANY MERISTEMs (BAM1-BAM3) form the CLV1 family (CLV1f), which perceives peptides of the CLV3/EMBRYO SURR
Like
Comment
Share
